Regulatory and health technology assessment of cell and gene therapies in Europe: Convergence or divergence?

被引：0
|
作者：
Hoogendoorn, Mark [1 ]
Fabriek, Babs [2 ]
Bloem, Lourens T. [1 ]
机构：
[1] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands
[2] Dutch Med Evaluat Board, Utrecht, Netherlands
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
61
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [1] Convergence, Divergence and Hybridity: A Regulatory Governance Perspective on Health Technology Assessment in England and Germany
    Wright, John S. F.
    Barron, Anthony J. G.
    Shah, Sara M. B.
    Klingler, Corinna
    GLOBAL POLICY, 2017, 8 : 69 - 75
  • [2] Future of health technology assessment studies in gene and cell therapies
    Yarpuzlu, Aysegul Akbay
    Atak, Nazli
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2007, 6 (14): : 1603 - 1607
  • [3] Recalibrating Health Technology Assessment Methods for Cell and Gene Therapies
    Aris Angelis
    Huseyin Naci
    Allan Hackshaw
    PharmacoEconomics, 2020, 38 : 1297 - 1308
  • [4] Recalibrating Health Technology Assessment Methods for Cell and Gene Therapies
    Angelis, Aris
    Naci, Huseyin
    Hackshaw, Allan
    PHARMACOECONOMICS, 2020, 38 (12) : 1297 - 1308
  • [5] HEALTH TECHNOLOGY ASSESSMENT OF GENE THERAPIES FOR INHERITED GENETIC DISORDERS IN THE US AND EUROPE
    Hollier-Hann, G.
    Cork, D.
    Ralston, S.
    Curry, A.
    VALUE IN HEALTH, 2018, 21 : S210 - S210
  • [6] Health technology assessment for gene therapies in haemophilia
    O'Hara, Jamie
    Neumann, Peter J.
    HAEMOPHILIA, 2022, 28 : 19 - 26
  • [7] REAL-WORLD EVIDENCE RECOMMENDATIONS FOR GENE THERAPIES: REGULATORY VERSUS HEALTH TECHNOLOGY ASSESSMENT
    Allen, G.
    Summers, D. M.
    Evans, J.
    VALUE IN HEALTH, 2020, 23 : S21 - S21
  • [8] HEALTH TECHNOLOGY ASSESSMENT (HTA) REVIEW OF CELL & GENE THERAPIES: THE ROAD TO REIMBURSEMENT
    Vu, B. K.
    Forsythe, A.
    Nguyen, K.
    Tomaras, D.
    VALUE IN HEALTH, 2020, 23 : S20 - S20
  • [9] ARE HEALTH TECHNOLOGY ASSESSMENT (HTA) BODIES RESPONDING TO THE ASSESSMENT CHALLENGES POSED BY CELL AND GENE THERAPIES?
    Fornaro, G.
    Drummond, M.
    Ciani, O.
    Jommi, C.
    VALUE IN HEALTH, 2022, 25 (07) : S297 - S297
  • [10] THE HEALTH-CARE STATE IN EUROPE - CONVERGENCE OR DIVERGENCE
    MORAN, M
    ENVIRONMENT AND PLANNING C-GOVERNMENT AND POLICY, 1992, 10 (01): : 77 - 90
12345